North America Male Urinary Incontinence Market Size, Share, and Growth Forecast 2026 - 2033

The North America male urinary incontinence market size is expected to be valued at US$ 3.1 billion in 2026 and projected to reach US$ 4.6 billion by 2033, growing at a CAGR of 5.8% between 2026 and 2033.

Growing prevalence of prostate-related conditions among aging men is the foremost catalyst behind this expansion, compounded by rising diagnosis rates as stigma surrounding male incontinence continues to decline. The American Cancer Society estimates that more than 313,000 new prostate cancer cases will be diagnosed in the U.S. in 2026, a leading contributor to post-surgical urinary incontinence. Simultaneously, the U.S. Census Bureau projects continued growth in the population aged 65 and older, widening the addressable patient base for absorbent, catheter-based, and external collection incontinence products.

Drivers - Rising Incidence of Prostate Cancer and Post-Prostatectomy Incontinence

Prostate cancer remains one of the most commonly diagnosed cancers among men in North America, and its surgical treatment is a well-documented cause of urinary incontinence. The American Cancer Society estimates that approximately 1 in 8 men will be diagnosed with prostate cancer during their lifetime, while the National Cancer Institute reports that radical prostatectomy, a common treatment pathway, carries a meaningful risk of post-surgical stress incontinence. This reality is driving sustained demand for absorbent pads, protective underwear, and external collection devices among recovering patients.

As survival rates improve and more men live longer after treatment, the population requiring ongoing continence management continues to expand, reinforcing consistent product demand across hospitals, specialty urology clinics, and home care settings.

Growing Aging Male Population and Rising Prevalence of Benign Prostatic Hyperplasia

An expanding elderly male population is directly increasing the prevalence of urge and overflow incontinence linked to benign prostatic hyperplasia (BPH). The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) notes that more than 50% of men in their 60s and up to 90% of men in their 70s and 80s experience BPH symptoms that can contribute to urinary leakage. The U.S. Census Bureau further projects that Americans aged 65 and above will represent a growing share of the population through 2033. This demographic shift is compelling healthcare providers and caregivers to scale up procurement of catheters, absorbent guards, and incontinence bedding products across both institutional and home care environments.

Restraints - High Cost of Advanced Continence Management Products and Limited Reimbursement

Advanced incontinence solutions, including specialized external collection devices and connected catheter systems, carry higher costs than conventional absorbent products, limiting broader adoption. Reimbursement coverage under Medicare and private insurance plans for durable incontinence supplies varies considerably and often excludes premium product categories, shifting out-of-pocket burden onto patients and caregivers. This cost sensitivity is especially pronounced within home care settings, where recurring purchases of pads, diapers, and guards represent an ongoing financial commitment. Consequently, price-conscious consumers frequently opt for lower-cost alternatives, tempering the overall growth pace of premium product segments in the market.

Opportunities - Technological Advancement in External Collection Devices and Connected Catheter Systems

Innovation in external collection devices and catheter technology presents a significant opportunity for market participants to differentiate their offerings. Companies including Coloplast A/S and Teleflex Incorporated have introduced next-generation external catheter systems designed to improve comfort, reduce skin complications, and extend wear time compared with legacy designs. Growing clinical interest in intermittent self-catheterization protocols, supported by urology associations, is also expanding the addressable base for pre-lubricated and coated catheter products. As hospitals and specialty urology clinics increasingly prioritize infection control and patient comfort, demand for technologically advanced, single-use collection systems is expected to rise steadily, creating durable opportunities for manufacturers investing in material science and design innovation.

Product Analysis

Absorbent Pads emerged as the leading product segment in the North America male urinary incontinence market, accounting for nearly 33% share in 2026. Their dominance is attributed to widespread affordability, ease of use, and suitability for managing mild-to-moderate incontinence without requiring clinical intervention, making them the default first-choice product for both home care and institutional settings. Manufacturers such as Essity AB (TENA) and Kimberly-Clark Corporation continue to expand pad product lines with improved absorbency and odor control technology, reinforcing consumer preference.

Meanwhile, External Collection Devices are projected to be the fastest-growing product segment through 2033, supported by rising clinical adoption of external catheter systems as a non-invasive alternative for men managing moderate to severe urinary leakage.

Incontinence Type Analysis

Stress Urinary Incontinence represented the leading incontinence type segment, holding an estimated 31% share of the market in 2025. This leadership position is closely tied to the high volume of post-prostatectomy patients, since surgical removal of the prostate frequently compromises the urinary sphincter, resulting in stress-related leakage during physical exertion.

Clinical literature referenced by the National Institutes of Health (NIH) consistently identifies prostate surgery as the predominant cause of male stress incontinence in North America, sustaining strong demand for absorbent pads and external collection devices among this patient group. Urge Urinary Incontinence, closely linked to benign prostatic hyperplasia and overactive bladder, is expected to be the fastest-growing incontinence type through 2033 as the aging male population expands.

Distribution Channel Analysis

Pharmacies & drug stores remained the leading distribution channel, accounting for an estimated 35% share of the market in 2026. Their leadership stems from consistent consumer trust in pharmacy staff for product guidance, along with the convenience of purchasing incontinence supplies alongside other prescribed medications.

National pharmacy chains across the U.S. and Canada continue to expand dedicated continence care aisles, reinforcing this channel's accessibility. Online Retail, however, is projected to be the fastest-growing distribution channel through 2033, driven by rising consumer preference for discreet, subscription-based purchasing that avoids the perceived embarrassment of in-store transactions, a trend increasingly supported by direct-to-consumer platforms operated by leading manufacturers.

U.S. Male Urinary Incontinence Market Size

The U.S. dominated the North America male urinary incontinence market, accounting for 83% of the regional share in 2025 and reaching an estimated market value exceeding US$2.5 billion in 2026. The country’s large aging male population, high prevalence of prostate-related conditions, and increasing incidence of prostate cancer contribute to sustained demand for urinary continence products. The American Cancer Society identifies prostate cancer as the most commonly diagnosed cancer among U.S. men, reinforcing the need for urinary management following prostate-related treatments and procedures.

The market is further supported by the U.S.’s highly developed healthcare infrastructure, extensive pharmacy networks, specialty medical suppliers, and expanding home healthcare services. Demand is increasing across absorbent products, external catheters, urinary drainage systems, and other continence-management solutions, particularly among older men requiring long-term care. Growing awareness of male-specific continence products, improved product comfort, and increasing adoption of home-based healthcare are also strengthening market penetration. These factors collectively reinforce the U.S. as the largest contributor to the North American male urinary incontinence market.

Canada Male Urinary Incontinence Market Size

Canada is projected to be the fastest-growing market within North America, supported by its aging male population and increasing need for continence-management solutions. Rising life expectancy is expanding the population of older men who are more susceptible to urinary incontinence associated with aging, prostate disorders, neurological conditions, and post-surgical complications. Statistics Canada data showing continued growth in the older population provides a favorable demographic foundation for increasing demand for male urinary incontinence products across the country.

Canada’s publicly funded healthcare system and expanding home and community care programs are also supporting greater access to continence-management products. Demand is expected to increase for absorbent products, external catheters, urinary drainage bags, and other non-invasive solutions, particularly among elderly and homebound patients. Greater awareness among healthcare professionals and patients, improved access to urological services, and increasing preference for home-based care are expected to further support market expansion. These factors position Canada as an important growth market within North America through 2033.

The North America male urinary incontinence market is moderately consolidated, led by established medical device and consumer health companies such as Coloplast A/S, Hollister Incorporated, and Essity AB (TENA). Competitive strategy centers on continuous product innovation in skin-friendly materials, odor-control technology, and coated catheter surfaces designed to minimize infection risk. Key differentiators among market leaders include broad distribution partnerships with pharmacy chains, direct-to-consumer subscription programs, and clinical education initiatives targeting urologists.

Emerging business trends include expansion of discreet online retail channels and strategic acquisitions aimed at broadening product portfolios across the continence care continuum, from absorbent products to advanced catheter systems.

Key Developments:

• In April 2026, Wellspect HealthCare launched Surity™ Male External Catheter in the U.S. market, expanding its continence care portfolio. The non-invasive device is designed for men managing urinary incontinence, focusing on improved comfort, dryness, dignity, and ease of use. The launch addresses growing demand for external urinary management solutions among patients requiring long-term continence support.
• In February 2025, First Quality Enterprises, LLC entered into a definitive agreement to acquire Henkel’s Retailer Brands business in North America. Following the acquisition, First Quality established First Quality Home Care Products as a dedicated business division within the First Quality Group to strengthen its presence in the home care products segment.